Cue Biopharma, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Cue Biopharma, Inc. (CUE) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- Cue Biopharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $233.00K, a 50.11% decline year-over-year.
- Cue Biopharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $880.00K, a 18.37% decline year-over-year.
- Cue Biopharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.19M.
- Cue Biopharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $764.00K.
- Cue Biopharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.11M.
- Cue Biopharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$150.00K, a 137.41% decline from fiscal 2023.
- Cue Biopharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $401.00K.
- Cue Biopharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$34.00K, a 167.41% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.11M 10-Q · filed 2026-08-14 | -$81.00K derived: sum of 3 quarters · filed 2026-08-14 | $683.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $880.00K 10-Q · filed 2026-05-14 | -$314.00K derived: sum of 2 quarters · filed 2026-05-14 | $450.00K derived: sum of 3 quarters · filed 2026-05-14 | $917.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$430.00K derived: sum of 2 quarters · filed 2026-03-16 | $37.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.11M 10-K · filed 2026-03-16 | ||
| 2025-09-30 | $764.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.23M derived: sum of 2 quarters · filed 2026-08-14 | $2.31M 10-Q · filed 2025-11-12 | $1.72M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.54M 10-Q · filed 2026-08-14 | $953.00K derived: sum of 3 quarters · filed 2026-08-14 | $613.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $1.08M 10-Q · filed 2026-05-14 | $486.00K derived: sum of 2 quarters · filed 2026-05-14 | $146.00K derived: sum of 3 quarters · filed 2026-05-14 | -$70.00K derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$592.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$932.00K derived: sum of 2 quarters · filed 2026-03-16 | -$1.15M derived: sum of 3 quarters · filed 2026-03-16 | -$150.00K 10-K · filed 2026-03-16 | ||
| 2024-09-30 | -$340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$556.00K derived: sum of 2 quarters · filed 2025-11-12 | $442.00K 10-Q · filed 2025-11-12 | $519.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $782.00K 10-Q · filed 2025-08-12 | $859.00K derived: sum of 3 quarters · filed 2025-08-12 | $113.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $998.00K 10-Q · filed 2025-05-12 | $1.07M derived: sum of 2 quarters · filed 2025-05-12 | $329.00K derived: sum of 3 quarters · filed 2025-05-12 | -$119.00K derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$669.00K derived: sum of 2 quarters · filed 2025-03-31 | -$1.12M derived: sum of 3 quarters · filed 2025-03-31 | $401.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$746.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.19M derived: sum of 2 quarters · filed 2024-11-14 | $324.00K 10-Q · filed 2024-11-14 | -$556.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$448.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.07M 10-Q · filed 2024-08-14 | $190.00K derived: sum of 3 quarters · filed 2024-08-14 | -$232.00K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $1.52M 10-Q · filed 2024-05-09 | $638.00K derived: sum of 2 quarters · filed 2024-05-09 | $216.00K derived: sum of 3 quarters · filed 2024-05-09 | $391.00K derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$880.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$1.30M derived: sum of 2 quarters · filed 2024-03-28 | -$1.13M derived: sum of 3 quarters · filed 2024-03-28 | -$34.00K 10-K · filed 2024-03-28 | -$33.60K 10-K · filed 2023-03-21 | |
| 2022-09-30 | -$422.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$247.00K derived: sum of 2 quarters · filed 2023-11-03 | $846.00K 10-Q · filed 2023-11-03 | $29.43K derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | $175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.27M 10-Q · filed 2023-08-08 | $451.43K derived: sum of 3 quarters · filed 2023-08-08 | -$1.47M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $1.09M 10-Q · filed 2023-05-09 | $276.43K derived: sum of 2 quarters · filed 2023-05-09 | -$1.64M derived: sum of 3 quarters · filed 2023-05-09 | -$446.57K derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | -$816.57K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | -$2.74M derived: sum of 2 quarters · filed 2023-03-21 | -$1.54M derived: sum of 3 quarters · filed 2023-03-21 | $50.43K 10-K · filed 2023-03-21 | ||
| 2021-09-30 | -$1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$723.00K derived: sum of 2 quarters · filed 2022-11-14 | $867.00K 10-Q · filed 2022-11-14 | $805.13K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.79M 10-Q · filed 2022-08-04 | $2.73M derived: sum of 3 quarters · filed 2022-08-04 | $1.83M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $1.59M 10-Q · filed 2022-05-10 | $1.53M derived: sum of 2 quarters · filed 2022-05-10 | $634.13K derived: sum of 3 quarters · filed 2022-05-10 | $977.13K derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -$61.87K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | -$955.87K derived: sum of 2 quarters · filed 2022-03-16 | -$612.87K derived: sum of 3 quarters · filed 2022-03-16 | $381.13K 10-K · filed 2022-03-16 | ||
| 2020-09-30 | -$894.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$551.00K derived: sum of 2 quarters · filed 2021-11-09 | $443.00K 10-Q · filed 2021-11-09 | $309.82K derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $343.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.34M 10-Q · filed 2021-08-09 | $1.20M derived: sum of 3 quarters · filed 2021-08-09 | $402.82K derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $994.00K 10-Q · filed 2021-05-10 | $860.82K derived: sum of 2 quarters · filed 2021-05-10 | $59.82K derived: sum of 3 quarters · filed 2021-05-10 | $281.82K derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | -$133.18K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$934.18K derived: sum of 2 quarters · filed 2021-03-09 | -$712.18K derived: sum of 3 quarters · filed 2021-03-09 | -$487.18K 10-K · filed 2021-03-09 | ||
| 2019-09-30 | -$801.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$579.00K derived: sum of 2 quarters · filed 2020-11-09 | -$354.00K 10-Q · filed 2020-11-09 | -$346.00K 10-Q · filed 2019-11-07 | $246.94K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $222.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $447.00K 10-Q · filed 2020-08-07 | $1.05M derived: sum of 3 quarters · filed 2020-08-07 | -$1.04M derived: sum of 4 quarters · filed 2020-08-07 | ||
| 2019-03-31 | $225.00K 10-Q · filed 2020-05-07 | $825.94K derived: sum of 2 quarters · filed 2020-05-07 | -$1.26M derived: sum of 3 quarters · filed 2020-05-07 | $445.94K derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2018-12-31 | $600.94K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$1.48M derived: sum of 2 quarters · filed 2020-03-12 | $220.94K derived: sum of 3 quarters · filed 2020-03-12 | $701.94K 10-K · filed 2020-03-12 | ||
| 2018-09-30 | -$2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$380.00K derived: sum of 2 quarters · filed 2019-11-07 | $101.00K 10-Q · filed 2019-11-07 | $917.68K derived: sum of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.19M 10-Q · filed 2019-08-08 | $3.00M derived: sum of 3 quarters · filed 2019-08-08 | $2.81M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | $481.00K 10-Q · filed 2019-05-08 | $1.30M derived: sum of 2 quarters · filed 2019-05-08 | $1.11M derived: sum of 3 quarters · filed 2019-05-08 | $1.58M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2017-12-31 | $816.68K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $624.68K derived: sum of 2 quarters · filed 2019-03-14 | $1.10M derived: sum of 3 quarters · filed 2019-03-14 | $1.12M 10-K · filed 2019-03-14 | ||
| 2017-09-30 | -$192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $280.00K derived: sum of 2 quarters · filed 2018-11-13 | $300.00K 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | $472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $492.00K 10-Q · filed 2018-08-13 | ||||
| 2017-03-31 | $20.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |